In 2018, there were an estimated 9.6 million deaths from cancers and 18.1 million new
cancer cases reported [1]. Unfortunately, the classical cancer treatments, such as …

Cancer is the second leading cause of death worldwide, and while science has advanced
significantly to improve the treatment outcome and quality of life in cancer patients, there are …

Background: Over the past five years, the cold atmospheric plasma-activated solutions
(PAS) have shown their promissing application in cancer treatment. Similar as the common …

An ideal cancer therapy would provide cure with nearly-zero adverse effects is the greatest
challenges of the 21st century for scientist belonging to medicine and many related fields …

Simple Summary During the last decade, cold atmospheric plasmas (CAP) have been
broadly investigated for their therapeutic effect against cancer. CAP sources can be used to …

Cancer is one of the major causes of mortality, accounting for∼ 9.5 million deaths globally in
2018. The spectrum of conventional treatment for cancer includes surgery, chemotherapy …

Background: Cold-atmospheric plasma (CAP) is an ionized gas produced at an atmospheric
pressure. The aim of this systematic review is to map the use of CAP in oncology and the …

Simple Summary One fundamental feature that has emerged from in vitro application of cold
plasmas in cancer treatment is the key role of the liquid phase covering the cells. In the …

This Special Issue on “Advances in Plasma Oncology Toward Clinical Translation” aims to
bring together cutting-edge research papers within the field in the context of clinical …

Plasma medicine is a relatively new field that grew from research in application of low-
temperature (or cold) atmospheric plasmas in bioengineering. One of the most promising …